These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 18320094)

  • 1. Managing acutely ill medical patients to reduce venous thromboembolic events.
    Cardiovasc J Afr; 2008; 19(1):57. PubMed ID: 18320094
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of the two-year outcomes and costs of prophylaxis in medical patients at risk of venous thromboembolism.
    Deitelzweig SB; Becker R; Lin J; Benner J
    Thromb Haemost; 2008 Nov; 100(5):810-20. PubMed ID: 18989525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prophylaxis and treatment of venous thromboembolism in cancer patients: a review.
    Ansell JE
    Am J Clin Oncol; 2009 Aug; 32(4 Suppl):S8-S12. PubMed ID: 19654482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in the safety profiles of two low-molecular-weight heparins.
    Ofosu FA
    Thromb Haemost; 2008 Jun; 99(6):989-90. PubMed ID: 18521496
    [No Abstract]   [Full Text] [Related]  

  • 5. Overview of current venous thromboembolism protocols in hip reconstruction.
    Lazo-Langner A; Rodger MA
    Orthop Clin North Am; 2009 Jul; 40(3):427-36. PubMed ID: 19576411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bleeding complications after systematic switch of routine thromboprophylaxis for major orthopaedic surgery.
    Kistler U; Kramers-de Quervain I; Munzinger U; Kucher N
    Thromb Haemost; 2008 Jun; 99(6):1049-52. PubMed ID: 18521507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticoagulation therapy for prevention and treatment of venous thromboembolic events in cancer patients: a review of current guidelines.
    Petersen LJ
    Cancer Treat Rev; 2009 Dec; 35(8):754-64. PubMed ID: 19762155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety of low-dose subcutaneous enoxaparin for the prevention of venous thromboembolism after primary intracerebral haemorrhage.
    Tetri S; Hakala J; Juvela S; Saloheimo P; Pyhtinen J; Rusanen H; Savolainen ER; Hillbom M
    Thromb Res; 2008; 123(2):206-12. PubMed ID: 18420258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk stratification and venous thromboprophylaxis in hospitalized medical and cancer patients.
    Prandoni P; Samama MM
    Br J Haematol; 2008 May; 141(5):587-97. PubMed ID: 18422787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and economic outcomes in patients at risk of venous thromboembolism receiving appropriate enoxaparin or unfractionated heparin prophylaxis.
    Amin AN; Lin J; Lenhart G; Schulman KL
    Thromb Haemost; 2009 Aug; 102(2):321-6. PubMed ID: 19652883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Venous thromboembolism risk in medical inpatients].
    Dini F; Moruzzo D; Bindi M; Pinelli M; Castiglioni M
    Recenti Prog Med; 2008; 99(7-8):354-62. PubMed ID: 18751614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Should all acutely ill medical patients be treated with antithrombotic drugs? A review of the interventional trials.
    Violi F; Perri L; Loffredo L
    Thromb Haemost; 2013 Apr; 109(4):589-95. PubMed ID: 23426236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Venous thromboembolic disease reduction with a portable pneumatic compression device.
    Froimson MI; Murray TG; Fazekas AF
    J Arthroplasty; 2009 Feb; 24(2):310-6. PubMed ID: 18534456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eradication of hospital-acquired venous thromboembolism.
    Goldhaber SZ
    Thromb Haemost; 2010 Dec; 104(6):1089-92. PubMed ID: 20806118
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of venous thromboembolism in patients with cancer: subgroup analysis of the Matisse clinical trials.
    van Doormaal FF; Raskob GE; Davidson BL; Decousus H; Gallus A; Lensing AW; Piovella F; Prins MH; Büller HR
    Thromb Haemost; 2009 Apr; 101(4):762-9. PubMed ID: 19350123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Major bleeding, mortality, and efficacy of fondaparinux in venous thromboembolism prevention trials.
    Eikelboom JW; Quinlan DJ; O'Donnell M
    Circulation; 2009 Nov; 120(20):2006-11. PubMed ID: 19884469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fondaparinux for prevention of venous thromboembolism in high-risk trauma patients: a pilot study.
    Lu JP; Knudson MM; Bir N; Kallet R; Atkinson K
    J Am Coll Surg; 2009 Nov; 209(5):589-94. PubMed ID: 19854398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deep-vein thrombosis in malignancy: how long should patients be treated, and with what?
    Merli GJ
    Catheter Cardiovasc Interv; 2009 Jul; 74 Suppl 1():S27-34. PubMed ID: 19530157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of anticoagulation in the management of pancreatic cancer.
    Sohail MA; Saif MW
    JOP; 2009 Mar; 10(2):82-7. PubMed ID: 19287098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The 8(th) American College of Chest Physicians Guidelines - a perspective on venous thromboembolism guidelines.
    Squizzato A; Ageno W
    Thromb Haemost; 2009 Jan; 101(1):31-5. PubMed ID: 19132186
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.